Fujifilm's Response to the COVID | 合法醫療器材資訊網

Fujifilm's Global Actions Against COVID-19 ... On April 9, 2020, FUJIFILM Corporation announced the initiation of a phase II clinical trial to evaluate the safety ... Read More

2021年4月21日 — While the pathology of COVID-19 has yet to be fully elucidated, there has been a necessity for effective treatment drugs as quickly as possible. Read More

FUJIFILM Holdings America Corporation's Commitment during the Novel Coronavirus (COVID-19) Pandemic. Read More

2021年3月30日 — Fujifilm launches “FUJIFILM COVID-19 Ag Test”, a SARS-CoV-2 antigen rapid diagnostic test with a highly-sensitive detection technology based on ... Read More

FUJIFILM Toyama Chemical Co., Ltd. Website. Learn about corporate information, ... Information of Avigan Tablet in relation to Covid-19Learn more ... Read More

Fujifilm has begun development of AI-based technologies that support diagnosis and treatment assesement of COVID-19 pneumonia by for example, evaluating the ... Read More

This is the Fujifilm Global Website. Fujifilm makes no representation that products on this website are commercially available in all countries. Read More

FUJIFILM Toyama Chemical began a phase III clinical trial of Avigan in Japan in March 2020, for COVID-19 patients with non-severe pneumonia and confirmed, with ... Read More

FUJIFILM Holdings' sustainability efforts including strengthening corporate governance and environmental ... Learn more about our activity against COVID-19. Read More